Category: Guided Therapeutics Inc.Syndicate content

Guided Therapeutics gets its day with the FDA

April 11, 2014 by Arezu Sarvestani

As requested, Guided Therapeutics gets a sit-down with the FDA to discuss a renewed bid to land approval for its LuViva cervical scanner.

Guided Therapeutics gets its day with the FDA

Guided Therapeutics (OTC:GTHP) is getting its requested date with the FDA's medical device regulators, during which the company hopes to revive its rejected bid to win approval for the LuViva cervical scanner.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Guided Therapeutics wants a sit-down with FDA

March 27, 2014 by Brad Perriello

Guided Therapeutics asks the FDA for a face-to-face meeting to discuss the revival of its approval bid for the LuViva cervical scanner.

Guided Therapeutics wants a sit-down with FDA

Guided Therapeutics (OTC:GTHP) said it's asked the FDA for a face-to-face meeting as it tries to resurrect the pre-market approval application for its LuViva cervical scanning device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Philips promotes home health chief to North America CEO | Personnel Moves

February 5, 2014 by Arezu Sarvestani

Philips names Brent Shafer its new CEO for North America, promoting him from chief of the home healthcare solutions group.

fired/hired

Technology giant Philips (NYSE:PHG) named a new North America CEO this week, promoting home health solutions chief Brent Shafer to replace Greg Sebasky, who retired this week.

Guided Therapeutics widens distribution after FDA disappointment

October 14, 2013 by Arezu Sarvestani

Guided Therapeutics signs distribution deals to gain access to 86 million new potential patients, hoping to land a win after the FDA refused to accept the company's premarket approval application.

Guided Therapeutics widens distribution after FDA disappointment

Georgie-based Guided Therapeutics (OTC:GTHP) hasn't won many points after announcing increased distribution for its LuViva advanced cervical scanning system.

More FDA hurdles for cervical scanning system sink Guided Therapeutic shares

September 9, 2013 by Arezu Sarvestani

Guided Therapeutics shares drop nearly 20% as the company faces more regulatory setbacks in getting its LuViva advanced cervical scanning system onto the U.S. market.

More FDA hurdles for cervical scanning system sink Guided Therapeutic shares

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AngioDynamics lets sales manager Panzer go | Personnel Moves

May 30, 2013 by Sony Salzman

AngioDynamics lets U.S. sales general manager Alan Panzer go "without cause."

keys: angiodynamics, cfo, alan panzer

fired/hired

Albany, N.Y.-based AngioDynamics (NSDQ:ANGO) said Alan Panzer, its general manager of U.S. sales, will no longer be with the company as of July 31, 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp